For the Inventor, By the Inventor

Enter inventor name

Acton, MA, United States of America

Yanbin Liu

USPTO Granted Patents = 18 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 7.8

ph-index = 5

Forward Citations = 56(Granted Patents)

Company Filing History:

Years Active: 2009-2015

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8962619 - Substituted imidazopyridinyl-aminopyridine compounds (2015-02-24),

2. 8815854 - Substituted imidazopyridinyl compounds (2014-08-26),

3. 8614228 - Quinone prodrug compositions and methods of use (2013-12-24),

4. 8609688 - Substituted imidazopyridinyl-aminopyridine compounds (2013-12-17),

5. 8580803 - Substituted pyrrolo-aminopyrimidine compounds (2013-11-12),

6. 8569331 - Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds (2013-10-29),

7. 8563567 - Substituted heterocyclic compounds (2013-10-22),

8. 8541407 - Substituted benzo-pyrido-triazolo-diazepine compounds (2013-09-24),

9. 8501770 - Substituted imidazopyridinyl-aminopyridine compounds (2013-08-06),

10. 8357694 - Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds (2013-01-22),

11. 8349827 - Substituted dipyrido-pyrimido-diazepine and benzo-pyrido-pyrimido compounds (2013-01-08),

12. 8304425 - Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer (2012-11-06),

13. 8114873 - 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase (2012-02-14),

14. 8067459 - Lapachone compounds and methods of use thereof (2011-11-29),

15. 7902192 - Inhibitors of P38 and methods of using the same (2011-03-08),

Title: Yanbin Liu - A Recognized Innovator in Pharmaceutical Compounds

Introduction

Yanbin Liu is a notable inventor based in Acton, MA, recognized for his significant contributions to the field of pharmaceutical chemistry. With 18 patents to his name, he has made advancements that could potentially change treatments for cell proliferative disorders, including cancer.

Latest Patents

Among his latest innovations are the "Substituted imidazopyridinyl-aminopyridine compounds," which involve the synthesis of new compound structures. This invention also encompasses pharmaceutical compositions that incorporate these compounds for the treatment of diseases such as cancer. Another noteworthy patent is for "Substituted imidazopyridinyl compounds," which similarly focuses on methods of synthesizing these compounds and their application in treating proliferative disorders through pharmaceutical approaches.

Career Highlights

Yanbin Liu has established a commendable career at Arqule, Inc., where he has played a vital role in advancing research in pharmaceutical compounds. His innovative work has laid the groundwork for potential therapeutic applications, showcasing his dedication to improving medical treatments through scientific discovery.

Collaborations

Throughout his career, Yanbin has collaborated with various professionals, including his coworkers Mark Anthony Ashwell and Manish Tandon. These partnerships have fostered a dynamic work environment that promotes shared knowledge and innovation in their field.

Conclusion

Yanbin Liu's contributions to pharmaceutical chemistry are marked by his extensive patent portfolio and collaborative spirit. His commitment to developing innovative treatments for serious health issues makes him a key figure in the realm of scientific research and invention. His work stands as a testament to the impact inventors can make on society through their innovations.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…